DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lambrechts D, Claes B, Delmar P et al.
VEGF pathway genetic variants as biomarkers of treatment outcome with
bevacizumab: an analysis of data from the AViTA and AVOREN randomised
trials.
Lancet Oncol 2012;
13: 724-733
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.